Early inflammation in the airways of a cystic fibrosis foetus

Slides:



Advertisements
Similar presentations
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response  Helle Krogh Johansen, Kasper.
Advertisements

J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Alveolar inflammation in cystic fibrosis
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery  J. Abbott, J.S. Elborn, A.M. Georgiopoulos,
Highlights of a workshop to discuss targeting inflammation in cystic fibrosis  Katharine H. Banner, Hugo De Jonge, Stuart Elborn, Ellena Growcott, Erich.
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response  Helle Krogh Johansen, Kasper.
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice  Bob Lubamba, François Huaux, Jean Lebacq, Etienne Marbaix,
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Ontogeny of pulmonary cyclooxygenase-1 (COX-1) and -2 (COX-2)
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Andrew J. Ghio, Victor L. Roggli, Joleen M. Soukup, Judy H
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Pro-inflammatory effect of cystic fibrosis sputum microparticles in the murine lung  Chiara Porro, Sante Di Gioia, Teresa Trotta, Silvia Lepore, Maria.
Fiona K. Dunlevy, S. Lorraine Martin, Francine de Courcey, J
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis  Catriona Kelly, Mark T. Williams, J. Stuart.
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Vitamin A and lung function in CF
Amyloidosis in cystic fibrosis: A case series
A.H. Gifford  Journal of Cystic Fibrosis 
Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure  I.J. Clifton, A.M. Morton, N.S. Ambrose,
Demographics of glucose metabolism in cystic fibrosis
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Absence of a gender gap in survival
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Uta Griesenbach, A. Christopher Boyd  Journal of Cystic Fibrosis 
Presentation transcript:

Early inflammation in the airways of a cystic fibrosis foetus Catherine Verhaeghe, Katty Delbecque, Laurence de Leval, Cecile Oury, Vincent Bours  Journal of Cystic Fibrosis  Volume 6, Issue 4, Pages 304-308 (July 2007) DOI: 10.1016/j.jcf.2006.12.001 Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Over-expression of pro-inflammatory proteins in a CF foetal lung. Control (A, C, E, G, I) and CF (B, D, F, H, J) foetal lungs were stained for ICAM-1 (A, B), COX-2 (C, D), Gro-β ( E, F), Gro-γ (G, H) and MMP-1 (I, J) expressions. Arrows indicate over-expressed pro-inflammatory molecules in bronchiolar epithelial cells (A–D), in endothelial cells (G, H) or in cartilage (I, J). Arrowheads indicate Groγ expression in monocytes. Original magnification, ×200 (A–F, I–J), ×400 (G, H). Journal of Cystic Fibrosis 2007 6, 304-308DOI: (10.1016/j.jcf.2006.12.001) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Nuclear localization of p65 in the CF foetal lung. Control foetal lungs (A) and ΔF508-CFTR foetal lungs (B) were stained for p65 (A, B) localization. Cell nuclear DNA was stained with TOTO-3 (C–D). Original magnification, ×63. Journal of Cystic Fibrosis 2007 6, 304-308DOI: (10.1016/j.jcf.2006.12.001) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions